Although hypertrophic scars are a common complication in a high percentage of burn injuries, to date their optimal treatment still remains to be established. Herein, the antiproliferative effect of Imiquimod on human fibroblasts is evaluated and an innovative nanotechnological approach for Imiquimod delivery by pyromellitic βcyclodextrin-based nanosponges is proposed. We observed that Imiquimod inhibits cell proliferation and induces apoptosis of normal skin and hypertrophic scar fibroblasts. When incorporated into βcyclodextrin-based nanosponges, Imiquimod shows a high encapsulation efficiency and a slow and prolonged in vitro kinetic release. These features give Imiquimod-loaded nanosponges a greater antiproliferative effect on human fibroblasts and on an immortalized non-tumorigenic keratinocyte cell line, compared to free Imiquimod. In conclusion, we suggest that this innovative nanomedicine formulation could provide an important contribution to the prevention and therapy of post-burn hypertrophic scars by combining the antiproliferative capacity of Imiquimod with the ability of the nanosponges to enhance the drug activity.

Cyclodextrin-Based Nanosponges as a Nanotechnology Strategy for Imiquimod Delivery in Pathological Scarring Prevention and Treatment

BASTIANCICH, CHIARA;SCUTERA, SARA AGATA CATERINA;TROTTA, Francesco;CAVALLI, Roberta;MUSSO, Tiziana;
2014

Abstract

Although hypertrophic scars are a common complication in a high percentage of burn injuries, to date their optimal treatment still remains to be established. Herein, the antiproliferative effect of Imiquimod on human fibroblasts is evaluated and an innovative nanotechnological approach for Imiquimod delivery by pyromellitic βcyclodextrin-based nanosponges is proposed. We observed that Imiquimod inhibits cell proliferation and induces apoptosis of normal skin and hypertrophic scar fibroblasts. When incorporated into βcyclodextrin-based nanosponges, Imiquimod shows a high encapsulation efficiency and a slow and prolonged in vitro kinetic release. These features give Imiquimod-loaded nanosponges a greater antiproliferative effect on human fibroblasts and on an immortalized non-tumorigenic keratinocyte cell line, compared to free Imiquimod. In conclusion, we suggest that this innovative nanomedicine formulation could provide an important contribution to the prevention and therapy of post-burn hypertrophic scars by combining the antiproliferative capacity of Imiquimod with the ability of the nanosponges to enhance the drug activity.
2
4
311
324
http://www.aspbs.com/jnd.htm
Imiquimod, nanosponges, hypertrophic scar
Bastiancich, Chiara; Scutera, Sara; Alotto, Daniela; Cambieri, Irene; Fumagalli, Mara; Casarin, Stefania; Rossi, Silvia; Trotta, Francesco; Stella, Maurizio; Cavalli, Roberta; Musso, Tiziana; Castagnoli, Carlotta
File in questo prodotto:
File Dimensione Formato  
J nanopharmaceutics drug delivery 2014 pdf editoriale.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 696.06 kB
Formato Adobe PDF
696.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1522552
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact